Dark

Check out our API

AMED
Amedisys Inc
stock NASDAQ

Inactive

Aug 14, 2025

100.99USD+0.010%(+0.01)1,060,060

Pre-market

0.00USD-100.000%(-100.98)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

08:00AM EST Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for the fourth quarter and year ended December 31, 2021, after the market closes on February 23, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on February 24, 2022. GlobeNewswire Inc

Jan 26, 2022

04:15PM EST Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, has recognized 37 employees with the prestigious Spirit of Excellence Awards, one of the companys highest honors. GlobeNewswire Inc

Jan 10, 2022

08:00AM EST Amedisys Announces Paul Kusserows Retirement as GlobeNewswire Inc

Dec 29, 2021

08:00AM EST Amedisys to Present at the 40th Annual J.P. Morgan Healthcare GlobeNewswire Inc

Dec 21, 2021

06:48AM EST Barclays Maintains Overweight on Amedisys, Lowers Price Target to $213 Benzinga

Dec 8, 2021

09:14AM EST Amedisys Announces $5M Investment In ConnectRN Benzinga

Nov 30, 2021

05:00PM EST Amedisys to Present at the Bank of America Securities 2021 Virtual GlobeNewswire Inc

Nov 19, 2021

08:00AM EST Amedisys to Present at the Stephens Annual Investment Conference GlobeNewswire Inc

Nov 10, 2021

08:31AM EST Penn State Health Partners with Highmark Health and Contessa to Launch Home PR Newswire

Nov 8, 2021

11:25AM EST Analyst Ratings For Amedisys Benzinga

03:59AM EST Raymond James Maintains Outperform on Amedisys, Lowers Price Target to $225 Benzinga

Nov 4, 2021

12:08PM EDT What 12 Analyst Ratings Have To Say About Amedisys Benzinga

09:40AM EDT Credit Suisse Maintains Outperform on Amedisys, Raises Price Target to $205 Benzinga

09:21AM EDT Stephens & Co. Maintains Equal-Weight on Amedisys, Raises Price Target to $185 Benzinga

08:34AM EDT RBC Capital Maintains Outperform on Amedisys, Lowers Price Target to $221 Benzinga

05:26AM EDT SVB Leerink Maintains Market Perform on Amedisys, Raises Price Target to $181 Benzinga

Nov 3, 2021

12:33PM EDT Analyst Ratings For Amedisys Benzinga

09:19AM EDT Oppenheimer Maintains Outperform on Amedisys, Lowers Price Target to $225 Benzinga

Nov 2, 2021

05:10PM EDT Amedisys Q3 EPS $1.37 Vs. $2.16 Year Ago RTTNews

04:53PM EDT Amedisys Sees FY21 Adj. EPS $5.88-$5.93 vs $6.08 Est.; Sees Sales $2.2B-$2.205B vs $2.25B Est. Benzinga

04:49PM EDT Amedisys Q3 Adj. EPS $1.53 Beats $1.36 Estimate, Sales $553.50M Miss $568.37M Estimate Benzinga

04:49PM EDT Amedisys (AMED) reported a profit for third quarter that dropped from the same period last year. RTTNews

10:41AM EDT Earnings Scheduled For November 2, 2021 Benzinga

Oct 29, 2021

01:00PM EDT Price Over Earnings Overview: Amedisys Benzinga

Oct 25, 2021

08:00AM EDT Amedisys to Present at the Credit Suisse 30th Annual Virtual GlobeNewswire Inc

Oct 20, 2021

08:00AM EDT Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has closed on its acquisition of regulatory assets that allow the Company to establish home health care centers to fully service and expand the Charlotte and Raleigh, N.C. markets. GlobeNewswire Inc

Oct 13, 2021

01:39PM EDT Analyst Ratings For Amedisys Benzinga

01:38PM EDT Truist Securities Maintains Buy on Amedisys, Lowers Price Target to $190 Benzinga

08:00AM EDT Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for the third quarter ended September 30, 2021, after the market closes on November 2, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on November 3, 2021. GlobeNewswire Inc

Sep 30, 2021

08:30AM EDT Hospital Care at Home: Henry Ford Health System and Contessa Partner to Create New Choice for Patients Business Wire

Sep 27, 2021

01:45PM EDT SVB Leerink Launches Coverage Of 16 Stocks Across Healthcare Providers & Managed Care Given 'Public Equity Investors Demonstrating A Willingness To Finance Losses For Prospects For Growth'; Notes Every 1% Shift Of MA Premiums Creating A $2.7B Market Benzinga

12:52PM EDT What 9 Analyst Ratings Have To Say About Amedisys Benzinga

10:57AM EDT UPDATE: SVB Leerink On Amedisys Market Perform Initiation: Firm Notes Attributes Recent 40% Downturn To Valuation Compression Across High-Multiple Cost Containment Stories; Sees 'Powerful Mega-Trends Around The Home' To Drive Exceedingly Positive Backdrop Benzinga

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 Benzinga

05:55AM EDT SVB Leerink Initiates Coverage On Amedisys with Market Perform Rating, Announces Price Target of $170 Benzinga

Sep 24, 2021

01:55PM EDT Where Amedisys Stands With Analysts Benzinga

10:43AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021 Benzinga

05:08AM EDT UBS Initiates Coverage On Amedisys with Sell Rating, Announces Price Target of $150 Benzinga

Sep 20, 2021

05:16PM EDT Amedisys To Buy Regulatory Assets Allowing Co. To Establish Home Health Care Centers To Fully Service, Expand Charlotte, Raleigh, North Carolina Markets Benzinga

05:15PM EDT Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has signed a definitive agreement to acquire regulatory assets that allow the Company to establish home health care centers to fully service and expand the Charlotte and Raleigh, N.C. markets. GlobeNewswire Inc

Sep 10, 2021

07:36PM EDT Where Amedisys Stands With Analysts Benzinga

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021 Benzinga

05:27AM EDT Cowen & Co. Initiates Coverage On Amedisys with Market Perform Rating, Announces Price Target of $195 Benzinga

Aug 31, 2021

12:35PM EDT Analyst Ratings For Amedisys Benzinga

Aug 21, 2021

11:23AM EDT What 6 Analyst Ratings Have To Say About Amedisys Benzinga

Aug 20, 2021

01:56PM EDT Return on Capital Employed Overview: Amedisys Benzinga

Aug 11, 2021

07:56AM EDT Credit Suisse Maintains Outperform on Amedisys, Lowers Price Target to $250 Benzinga

Aug 10, 2021

10:48AM EDT Benchmark Maintains Buy on Amedisys, Lowers Price Target to $235 Benzinga

07:57AM EDT 10 Biggest Price Target Changes For Tuesday Benzinga

06:41AM EDT Raymond James Maintains Outperform on Amedisys, Lowers Price Target to $250 Benzinga

Aug 6, 2021

07:47AM EDT Oppenheimer Maintains Outperform on Amedisys, Lowers Price Target to $265 Benzinga

07:38AM EDT Stephens & Co. Maintains Equal-Weight on Amedisys, Lowers Price Target to $237 Benzinga

Aug 5, 2021

10:07AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021 Benzinga

06:26AM EDT B of A Securities Downgrades Amedisys to Neutral, Announces $220 Price Target Benzinga

Aug 4, 2021

05:16PM EDT Amedisys (AMED) released earnings for its second quarter that climbed from last year. RTTNews

05:12PM EDT Amedisys (AMED) Announces $100 Mln Stock Repurchase Plan RTTNews

05:11PM EDT Amedisys Sees FY21 Core Adj. EPS $6.37-$6.49, Adj. Service Revenue $2.23B-$2.245B; Says 'our Hospice segment is behind in both admission and average daily census growth' Benzinga

05:06PM EDT Amedisys Q2 EPS $2.43 Beats $1.67 Estimate, Sales $564.20M Miss $566.19M Estimate Benzinga

04:05PM EDT Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June30, 2021. GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Jul 12, 2021

08:00AM EDT Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, will report results for the second quarter ended June 30, 2021, after the market closes on August 4, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on August 5, 2021. GlobeNewswire Inc

Jul 7, 2021

08:00AM EDT Amedisys Completes Acquisition of Home Healthand GlobeNewswire Inc

Jun 30, 2021

05:30PM EDT Amedisys Announces Agreement to Acquire Contessa Health, Creating a Comprehensive Home Healthcare Delivery Platform Benzinga

05:30PM EDT Amedisys Announces Agreement to Acquire Contessa Health, Creating GlobeNewswire Inc

May 19, 2021

09:00AM EDT Amedisys to Present at Multiple Healthcare Conferences in June GlobeNewswire Inc

May 18, 2021

09:00AM EDT Modern Healthcare recently named Amedisys, Inc., one of the nations leading home health, hospice and personal care companies, to its prestigious Best Places to Work in Healthcare list. GlobeNewswire Inc

May 11, 2021

08:19AM EDT Visiting Nurse Association Reports Deal To Transition Home Health, Hospice Operations To Amedisys Benzinga

08:00AM EDT VNA Signs Agreement to Sell Home Health and Hospice Services to GlobeNewswire Inc

May 10, 2021

04:15PM EDT Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, and Chris Gerard, President and Chief Operating Officer, will present at the 2021 RBC Capital Markets Healthcare Conference on Tuesday, May 18, 2021. GlobeNewswire Inc

May 6, 2021

09:00AM EDT Amedisys, Inc. (NASDAQ: AMED), one of the nations leading home healthcare, hospice and personal care companies, celebrates National Nurses Week by honoring the thousands of nurses who call the company home. GlobeNewswire Inc

May 3, 2021

04:15PM EDT Amedisys, Inc. (NASDAQ: AMED), a leading provider ofquality home health, hospice and personal care, has closed on its acquisition of regulatory assets that allow the Company to conduct home health care operations in Randolph County, N.C. GlobeNewswire Inc

07:00AM EDT Amedisys to Present at the 2021 Bank of America Healthcare Conference GlobeNewswire Inc

Apr 28, 2021

05:28PM EDT Amedisys (AMED) reported earnings for its first quarter that rose from last year. RTTNews

04:48PM EDT Amedisys Q1 EPS $1.50 Vs. $0.96 Year Ago RTTNews

04:39PM EDT Amedisys Updates FY21 Guidance: Net Sales $2.302B-$2.342B, Adj. EPS $6.85-$7.07 vs $6.37 Estimate Benzinga

04:17PM EDT Amedisys Q1 EPS $1.54 Beats $1.43 Estimate, Sales $537.10M Miss $544.86M Estimate Benzinga

04:05PM EDT Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March31, 2021. GlobeNewswire Inc

04:15AM EDT Earnings Scheduled For April 28, 2021 Benzinga

Apr 27, 2021

10:19AM EDT Earnings Outlook For Amedisys Benzinga

Apr 14, 2021

05:00PM EDT Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, will report results for the first quarter ended March 31, 2021, after the market closes on April 28, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on April 29, 2021. GlobeNewswire Inc

07:40AM EDT Amedisys, Inc. (AMED) said it will acquire the right to operate certified home health care services in Randolph County, N.C., and surrounding areas within a 50-mile radius, including Montgomery County. The acquisition of regulatory assets will allow the company to conduct home health care operations in Randolph County, N.C. RTTNews

07:16AM EDT Amedisys To Buy Regulatory Assets That Allow Home Health Care Operations In Randolph County RTTNews

07:08AM EDT Amedisys Reports Will Buy Randolph Country Home Health Regulatory Asset, No Terms Disclosed Benzinga

07:00AM EDT Amedisys, Inc. (NASDAQ: AMED), a leading provider ofquality home health, hospice and personal care, has signed a definitive agreement to acquire regulatory assets that allow the Company to conduct home health care operations in Randolph County, N.C. GlobeNewswire Inc

Mar 15, 2021

07:00AM EDT Amedisys, Inc.(NASDAQ: AMED), a leading provider of home health, hospice and personal care, has repurchased approximately $73 million in stock beginning Monday, March 1. Late in 2020, the Amedisys Board of Directors authorized up to $100 million in share repurchases through December 31, 2021. GlobeNewswire Inc

Mar 1, 2021

04:15PM EST Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Chief Executive Officer, will present at both the 42nd Annual Raymond James Institutional Investors Conference and the Barclays Global Healthcare Conference. GlobeNewswire Inc

Feb 25, 2021

09:54AM EST P/E Ratio Insights for Amedisys Benzinga

Feb 24, 2021

05:33PM EST Amedisys: Q4 Earnings Insights Benzinga

04:32PM EST Amedisys (AMED) released earnings for its fourth quarter that climbed from the same period last year. RTTNews

04:26PM EST Amedisys Q4 EPS $1.49 Beats $1.47 Estimate, Sales $550.70M Miss $553.37M Estimate Benzinga

04:08PM EST Amedisys Q4 EPS $1.36 Vs $0.83 Last Year RTTNews

04:05PM EST Christopher Gerard named President and Chief Operating Officer and Scott Ginn named Executive Vice President and Chief Financial Officer GlobeNewswire Inc

04:05PM EST Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December31, 2020. GlobeNewswire Inc

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 23, 2021

11:31AM EST Benchmark Maintains Buy on Amedisys, Raises Price Target to $325 Benzinga

10:22AM EST Preview: Amedisys's Earnings Benzinga

Feb 9, 2021

04:15PM EST Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the fourth quarter and year ended December 31, 2020, after the market closes on February 24, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on February 25, 2021. GlobeNewswire Inc

Feb 8, 2021

12:26PM EST Deutsche Bank Maintains Buy on Amedisys, Raises Price Target to $340 Benzinga

Jan 5, 2021

08:09AM EST Amedisys, Option Care Health Collaborate To Provide COVID Antibody Infusion Therapy Within Skilled Nursing, Assisted Living Facilities Benzinga

08:00AM EST Leading Healthcare Services Organizations Collaborate to Provide GlobeNewswire Inc

Dec 30, 2020

04:30PM EST Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021. GlobeNewswire Inc

Dec 24, 2020

06:32AM EST A Peek Into The Markets: US Stock Futures Up Ahead Of Christmas Break Benzinga

Dec 23, 2020

04:16PM EST Amedisys Board Of Directors Authorizes A $100M Share Buyback Benzinga

04:15PM EST Amedisys, Inc. (NASDAQ: AMED), Americas leading independent home health, hospice and personal care company, today announced that its Board of Directors has authorized a stock repurchase program, under which the Company may repurchase up to $100 million of its outstanding common stock through December 31, 2021. GlobeNewswire Inc

Dec 15, 2020

08:00AM EST Amedisys, Inc.(NASDAQ: AMED), a leading provider of home health, hospice and personal care, announced today that Ivanetta Davis Samuels is joining its Board of Directors, effective December 15, 2020. GlobeNewswire Inc

Nov 16, 2020

04:30PM EST Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020. GlobeNewswire Inc

Oct 30, 2020

09:00AM EDT Credit Suisse Maintains Outperform on Amedisys, Raises Price Target to $280 Benzinga

Oct 28, 2020

04:52PM EDT Amedisys Q3 EPS $2.16 Vs $1.03 Last Year RTTNews

04:38PM EDT Amedisys: Q3 Earnings Insights Benzinga

04:37PM EDT Amedisys Sees FY20 Adj. EPS $6.02-$6.08, Adj. EBITDA $269M-$272M Benzinga

04:37PM EDT Amedisys Q3 Adj. EPS $2.24 Beats $1.28 Estimate, Sales $544.07M Beat $533.18M Estimate Benzinga

04:05PM EDT Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September30, 2020. GlobeNewswire Inc

Oct 27, 2020

10:24AM EDT Amedisys's Earnings Outlook Benzinga

Oct 13, 2020

04:15PM EDT Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the third quarter ended September 30, 2020, after the market closes on October 28, 2020. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on October 29, 2020. GlobeNewswire Inc

Sep 21, 2020

08:28AM EDT Oppenheimer Maintains Outperform on Amedisys, Raises Price Target to $260 Benzinga

Sep 2, 2020

11:19AM EDT BMO Capital Maintains Market Perform on Amedisys, Raises Price Target to $270 Benzinga

Aug 31, 2020

04:30PM EDT Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Baird 2020 Global Healthcare Conference on Thursday, September 10, 2020. GlobeNewswire Inc

Aug 24, 2020

04:30PM EDT Amedisys, Inc. (NASDAQ: AMED), Americas leading independent home health, hospice and personal care company, has signed a Care Coordination Agreement with BrightStar Care to add its agencies to the Amedisys Personal Care Network, which helps facilitate the coordination of care between Amedisys hospice and home health care centers and a network of personal care partners. GlobeNewswire Inc

Jul 30, 2020

10:27AM EDT SunTrust Robinson Humphrey Maintains Buy on Amedisys, Raises Price Target to $270 Benzinga

09:42AM EDT Raymond James Maintains Outperform on Amedisys, Raises Price Target to $255 Benzinga

09:11AM EDT Deutsche Bank Maintains Buy on Amedisys, Raises Price Target to $260 Benzinga

09:03AM EDT 10 Biggest Price Target Changes For Thursday Benzinga

08:09AM EDT Benchmark Maintains Buy on Amedisys, Raises Price Target to $250 Benzinga

06:39AM EDT RBC Capital Maintains Outperform on Amedisys, Raises Price Target to $260 Benzinga

Jul 29, 2020

09:14AM EDT Jefferies Maintains Buy on Amedisys, Raises Price Target to $250 Benzinga

Jul 28, 2020

11:13PM EDT Amedisys Inc. (AMED) reported that its net income attributable to the company for the second-quarter rose to $34.7 million or $1.04 per share from $33.7 million or $1.02 per share last year. RTTNews

06:12PM EDT Recap: Amedisys Q2 Earnings Benzinga

04:43PM EDT Amedisys Q2 EPS $1.04 Vs. $1.02 Year Ago RTTNews

04:11PM EDT Amedisys Q2 Adj. EPS $1.34 Beats $0.81 Estimate, Sales $485.00M Beat $469.13M Estimate Benzinga

04:05PM EDT Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month period ended June30, 2020. GlobeNewswire Inc

04:05AM EDT Earnings Scheduled For July 28, 2020 Benzinga

Jul 16, 2020

04:30PM EDT Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the second quarter ended June 30, 2020, after the market closes on July 28, 2020. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on July 29, 2020. GlobeNewswire Inc

Share